ISSN:
1619-7089
Keywords:
Myocardial perfusion
;
Tc radiopharmaceutical
;
biodistribution
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Hexakis (methoxyisobutilisonitrile) technetium(I), 99mTc-MIBI, has been proposed for myocardial perfusion studies. We have evaluated the biodistribution of this new agent in normal volunteers at rest and after stress. The biodistribution of 99mTc-MIBI is characterized by rapid blood clearance and a consequently early myocardial uptake. The initial intense hepatic activity is cleared into the gallbladder at 1 h after injection, and the best target to non target ratio is observed at 60–90 min after injection. Absorbed radiation dose calculations show that the thyroid is the critical target organ (230 mRad/mCi at rest), presumably because of 99mTc-pertechnetate generated in vivo. Our results indicate that 99mTc-MIBI is a promising tracer for myocardial perfusion imaging.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00256936
Permalink